Treatment of radiation dermatitis in the aspect of evidence base medicine

被引:2
作者
Topczewska-Bruns, Joanna [1 ]
Filipowski, Tomasz [1 ]
机构
[1] Bialostockie Ctr Onkol, Bialystok, Poland
来源
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY | 2010年 / 14卷 / 03期
关键词
radiotherapy; radiation dermatitis; skin care; skin reactions; PATIENTS RECEIVING RADIOTHERAPY; SQUAMOUS-CELL CARCINOMA; INDUCED SKIN TOXICITY; DOUBLE-BLIND; PHASE-III; BREAST IRRADIATION; PROPHYLACTIC AGENT; ALOE-VERA; MANAGEMENT; THERAPY;
D O I
10.5114/wo.2010.14134
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A large part of oncological patients will be treated using radiation therapy The effect of the action of ionizing radiation on the skin is radiation dermatitis, which may have a different level of intensity Skin reaction is a source of a number of ailments such as burning, itching or pain on the irradiated area A severe degree of radiation dermatitis can not only significantly impair quality of life of the patient, but also require the interruption of irradiation which can influence results Prevention and treatment of radiation skin reaction is a daily practice for radiotherapist, but unfortunately, there is little evidence on which to base therapeutic decisions This article presents a review of clinical trials for the prevention and treatment of radiation dermatitis.
引用
收藏
页码:223 / 228
页数:6
相关论文
共 32 条
  • [1] [Anonymous], J WOUND CARE
  • [2] [Anonymous], 2008, J WOUND CARE
  • [3] Evaluation of early and late Toxicities in chemoradiation trials
    Bentzen, Soren M.
    Trotti, Andrea
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (26) : 4096 - 4103
  • [4] Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck
    Bernier, J.
    Bonner, J.
    Vermorken, J. B.
    Bensadoun, R-J.
    Dummer, R.
    Giralt, J.
    Kornek, G.
    Hartley, A.
    Mesia, R.
    Robert, C.
    Segaert, S.
    Ang, K. K.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (01) : 142 - 149
  • [5] BERNIER J, 2009, MEDYCYNA PRAKTYCZNA, V1, P81
  • [6] Preliminary reliability and validity testing of a new Skin Toxicity Assessment Tool (STAT) in breast cancer patients undergoing radiotherapy
    Berthelet, E
    Truong, PT
    Musso, K
    Grant, V
    Kwan, W
    Moravan, V
    Patterson, K
    Olivotto, IA
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (06): : 626 - 631
  • [7] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
    Bonner, JA
    Harari, PM
    Giralt, J
    Azarnia, N
    Shin, DM
    Cohen, RB
    Jones, CU
    Sur, R
    Raben, D
    Jassem, J
    Ove, R
    Kies, MS
    Baselga, J
    Youssoufian, H
    Amellal, N
    Rowinsky, EK
    Ang, KK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) : 567 - 578
  • [8] Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis:: results from a double-blind, randomized study
    Boström, Å
    Lindman, H
    Swartling, C
    Berne, B
    Bergh, J
    [J]. RADIOTHERAPY AND ONCOLOGY, 2001, 59 (03) : 257 - 265
  • [9] Campbell I R, 1992, Clin Oncol (R Coll Radiol), V4, P78, DOI 10.1016/S0936-6555(05)80971-9
  • [10] Coulomb B, 1997, SKIN PHARMACOL, V10, P281